CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | Chan Phillip P. Chief Executive Officer | Purchase · Common Stock Warrant (Right to Buy) | +26,315 | 26,315 | ||
| 2023-09-18 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award | +45,000 | 442,347 | ||
| 2023-09-18 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-08-07 | BATOR MICHAEL G. Director | Purchase | +1,000 | $3.20 | $3K | 86,800 |
| 2023-08-07 | BATOR MICHAEL G. Director | Purchase | +1,000 | $3.15 | $3K | 87,800 |
| 2023-08-04 | BATOR MICHAEL G. Director | Purchase | +1,000 | $3.23 | $3K | 85,800 |
| 2023-07-07 | BLOCH KATHLEEN P. Interim CFO | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-07-07 | Chan Phillip P. Chief Executive Officer | Grant or award | +87,000 | 1,006,548 | ||
| 2023-07-07 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | −112,000 | 112,000 | ||
| 2023-07-07 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | −48,000 | 48,000 | ||
| 2023-07-07 | BATOR MICHAEL G. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-07-07 | Sobel Alan D. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-07 | Jones Edward Raymond Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-07 | Kim Jiny Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-07 | Capponi Vincent President & COO | Grant or award | +73,000 | 576,153 | ||
| 2023-07-07 | Capponi Vincent President & COO | Grant or award · Stock Option (right to buy) | +91,000 | 91,000 | ||
| 2023-07-07 | Capponi Vincent President & COO | Grant or award · Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2023-07-07 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +55,000 | 331,648 | ||
| 2023-07-07 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +78,000 | 78,000 | ||
| 2023-07-07 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 6 of 35 · 698 trades